MedPath

Bharat Biotech International Ltd.

Bharat Biotech International Ltd. logo
🇮🇳India
Ownership
Holding
Established
1996-01-01
Employees
501
Market Cap
-
Website
http://www.bharatbiotech.com

Clinical Trials

36

Active:1
Completed:34

Trial Phases

5 Phases

Phase 1:6
Phase 2:4
Phase 3:6
+2 more phases

Drug Approvals

9

PHILIPPINES:9

Drug Approvals

Hepliv

Approval Date
Jul 14, 2025
PHILIPPINES

Typbar

Approval Date
Jul 14, 2025
PHILIPPINES

Hepliv

Approval Date
Jul 14, 2025
PHILIPPINES

Hepliv

Approval Date
Jul 14, 2025
PHILIPPINES

Humog 150

Approval Date
Jul 14, 2025
PHILIPPINES

Indirab

Approval Date
Jul 14, 2025
PHILIPPINES

Tobralcin

Approval Date
Jul 14, 2025
PHILIPPINES

Revac B+

Approval Date
Jul 14, 2025
PHILIPPINES

Typbar

Approval Date
Jul 14, 2025
PHILIPPINES

Clinical Trials

Distribution across different clinical trial phases (36 trials with phase data)• Click on a phase to view related trials

Phase 4
17 (47.2%)
Phase 1
6 (16.7%)
Phase 3
6 (16.7%)
Phase 2
4 (11.1%)
phase_2_3
2 (5.6%)
Not Applicable
1 (2.8%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.